Patents
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
11/2002
11/13/2002CN1379068A Low foaming N-alkyl-tartraimine and N-alkyl melicimine wetting agent
11/13/2002CN1094126C Pyrroloazepine compounds
11/12/2002US6479668 Method of producing pyrrolidine derivatives
11/12/2002US6479667 Crystalline forms of antibiotic side chain intermediates
11/12/2002US6479587 Crosslinkable polyurea polymers
11/12/2002US6479554 Immunotherapeutic agents
11/12/2002US6479552 Use of substituted N, N-disubstituted diamino compounds for inhibiting cholesteryl ester transfer protein activity
11/12/2002US6479550 α-sulfenimino acid derivatives
11/12/2002US6479531 Gastrin and cholecystokinin receptor ligands
11/12/2002US6479524 To prolong the thrombin time
11/12/2002US6479518 Zwitterionic tachykinin receptor antagonists
11/12/2002US6479502 Hydroxamic acid derivatives as proteinase inhibitors
11/12/2002US6479265 Catalytic antibodies which hydrolyze primary amides and methods for eliciting and use of such antibodies
11/12/2002CA2144294C (pyrrolidinyl)phenyl carbamates and intermediate compounds, processes for their preparation and their use as medicaments
11/12/2002CA2034983C Dispersant compositions
11/07/2002WO2002088298A1 Compounds, compositions, and methods for controlling biofilms
11/07/2002WO2002088094A1 2-iminoimidazole derivatives (1)
11/07/2002WO2002088092A1 2-iminoimidazole derivative (2)
11/07/2002WO2002088082A2 Process for preparing hydroxypyrrolidinyl ethylamine compounds useful as kappa agonists
11/07/2002WO2002088073A1 Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof
11/07/2002WO2002088071A1 20-hydroxyeicosatetraenoic acid production inhibitors
11/07/2002WO2002087759A1 Polymer-bound catalyst for the enantioselective aldol or mannich reaction
11/07/2002WO2002064546A3 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/07/2002US20020165398 Amino-thiophene-amido derivatives
11/07/2002US20020165232 Substituted N, N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
11/07/2002US20020165231 Substituted N-heteroaryl-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
11/07/2002US20020165223 Eating disorders; anticholesterol agents; hypotensive agents; sleep disorders
11/07/2002US20020165167 Bacterial polypeptide deformylase (PDF) inhibitors, N-formyl hydroxylamine derivatives
11/07/2002CA2445874A1 Process for preparing hydroxypyrrolidinyl ethylamine compounds useful as kappa agonists
11/07/2002CA2445591A1 Nitrogen heterocyclic compounds and compositions for controlling biofilms
11/06/2002EP1254907A1 Pyrrolopyridazine compound
11/06/2002EP1254895A1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
11/06/2002EP1254136A1 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF
11/06/2002EP1254115A2 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases
11/06/2002EP1254113A1 N-substituted 2-cyanopyroles and -pyrrolines which are inhibitors of the enzyme dpp-iv
11/06/2002EP1253922A2 Statin-type bone growth stimulators
11/06/2002EP1253916A1 Method of treating vaginal dryness with nicotinic acetylcholine receptor agonists
11/06/2002CN1378532A Substituted 1,5-dihydropyrrol-2-on derivatives as NMDA receptor antagonists for treatment of pain
11/06/2002CN1378531A Substituted pyrolidine-2,3,4-trion-3-oxime derivatives useful as NMDA receptor antagonists
11/06/2002CN1378527A Biaryl ether derivatives useful as monoamine reuptake inhibitors
11/06/2002CN1378446A Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
11/06/2002CN1377879A New alpha-amino acid sulfuryl compounds, its preparing method and medicinal composition containing them
11/06/2002CN1377647A 4-mercaptopyrrolidinyl derivative as fernesyl transferase inhibitor
11/06/2002CN1093856C Substituted sulfonic acid N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclamide compounds
11/06/2002CN1093853C New method for preparing (S)-4-amino-hepta-5,6-dienoic acid and intermediate thereof
11/06/2002CN1093760C Use of carbazole compounds for treating congenstive heart failure medicine
11/05/2002US6476264 N-(4-carbamimidoyl-phenyl)-glycine derivatives
11/05/2002US6476235 Process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide
11/05/2002US6476075 Use of substituted N, N-bis-benzyl aminoalcohol compounds inhibiting cholesteryl ester transfer protein activity
11/05/2002US6476063 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
11/05/2002US6476062 Chemokine receptor antagonists
11/05/2002US6476061 Fungicides containing pyrrolidones as their active agents
11/05/2002US6476057 Use of substituted N, N-disubstituted cycloalkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
11/05/2002US6476053 Mycobacterial inhibitors
11/05/2002US6476027 N-hydroxy 4-sulfonyl butanamide compounds
11/05/2002US6476026 Compounds and compositions as protease inhibitors
11/05/2002US6476023 Aromatic heterocyclic compounds as anti-inflammatory agents
11/05/2002CA2038379C Trifluoromethyl mercaptan and mercaptoacyl derivatives and method of using same
11/05/2002CA2038029C 1-alkyl-, 1-alkenyl- and 1-alkynylaryl-2-amino-1,3-propanediols and related compounds, a process and intermediates for their preparation and theeir use as medicaments
10/2002
10/31/2002WO2002085925A2 Melanocortin receptor ligands
10/31/2002WO2002085855A1 2-iminopyrrolidine derivatives
10/31/2002WO2002085853A2 Heterocyclylalkoxy-, -alkylthio- and -alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
10/31/2002WO2002085852A1 Pyrrole compound and agricultural or horticultural bactericide
10/31/2002WO2002085851A1 Pyrrole derivative
10/31/2002WO2002085850A1 Cyclic amidine derivative
10/31/2002WO2002085838A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/31/2002WO2002085350A1 Prodigiosin composition for the treatment of rheumatic arthritis
10/31/2002WO2001058855A9 Use of androgen receptor suppressors
10/31/2002US20020161252 Zinc complex with a chiral ligand, such as diethylzinc((S,S)-N-N'-ethylene-bis-(1-phenylethylamine))
10/31/2002US20020161241 Process for preparing hydroxypyrrolidinyl ethylamine compounds useful as kappa agonists
10/31/2002US20020161240 Synthetic multimerizing agents
10/31/2002US20020161239 Process for producing crystalline atorvastatin calcium
10/31/2002US20020161033 Substituted 1,5-dihydropyrrol-2-one derivatives active as NMDA receptor antagonists for treatment of states of pain
10/31/2002US20020161024 Administering 2-(piperidin-2,6-dion-3-yl),4-amino-isoindolin-1-one to treat an eye condition
10/31/2002US20020161021 Beta hydroxy ketone treated with trialkylborane or dialkylalkoxyborane followed by recovery and reuse of alkylborane
10/31/2002US20020160501 Methods for generating high titer helper-free preparations of released recombinant AAV vectors
10/31/2002US20020159973 Administering to the patient at least one statin (HMG-Coa-reductase inhibitor) in an amount effective to modulate MHC class II (Major Histocompability complex) or CD/40(antigen) expression in the patient
10/31/2002CA2444599A1 Melanocortin receptor ligands
10/31/2002CA2444036A1 Heterocyclylalkoxy-, -alkylthio- and -alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
10/30/2002WO2001083444A1 Method for producing cyclic lactams
10/30/2002EP1252166A1 Olefin polymerization cocatalysts derived from group-15 cationic compounds and processes using them
10/30/2002EP1252141A1 Tosylproline analogs as thymidylate synthase inhibitors
10/30/2002EP1252140A1 Pyrrolecarboxamides and pyrrolethioamides as fungicides
10/30/2002EP1252139A1 Trifluoromethylpyrrole carboxamides and trifluoromethylpyrrolethioamides as fungicides
10/30/2002EP1251822A1 Novel coupler for use in oxidative hair dyeing
10/30/2002CN1377376A Recovery of modifier compounds and polar organic compounds from a poly (arylene sulfide)
10/30/2002CN1377350A Process for production of naphthyridine-3-carboxylic acid derivatives
10/30/2002CN1377341A Amycomycin, production thereof and its use as pharmaceutical
10/30/2002CN1377268A Cell adhesion inhibitors
10/30/2002CN1376661A Indandione compounds and its preparing process and application
10/30/2002CN1376659A Process for preparing chiral desubstituted carbinol with high selectivity
10/30/2002CA2407813A1 Method for producing cyclic lactams
10/29/2002US6472537 Polyamides for binding in the minor groove of double stranded DNA
10/29/2002US6472529 Viricides
10/29/2002US6472526 Shows an inhibitory activity against farnesyl transferase or pharmaceutically acceptable salts or isomers thereof, in pharmaceutical composition and intermediates
10/29/2002US6472466 Reaction product of a multi-functional aldehyde with an amine having an electron withdrawing group at the alpha position; imine-ester undergoes cycloaddition curing with unsaturated acid of an unsaturated polyester to form an enamel
10/29/2002US6472421 Methods for treating, preventing, and reducing the risk of the onset of alzheimer's disease using an HMG CoA reductase inhibitor
10/29/2002US6472419 1-H-3-aryl-pyrrolidine-2, 4-dione derivatives as pest-control agents
10/29/2002US6472415 Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes
10/29/2002US6472414 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method